Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02188511 · ClinicalTrials.gov registry record · NA
Effects of Electronic Cigarettes on Lung Biology
A NA study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT02188511 is a NA study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 13 participants.
The verdict
NCT02188511, a NA study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
E-cigarettes are an increasingly popular alternate nicotine delivery system, but nothing is known about the effects of electronic cigarettes on the lungs. We hypothesize that e-cigarettes disorder airway epithelial and alveolar macrophages biology. Our goal is not to carry out a large epidemiologic study of electronic cigarette users to study lung function and other possible abnormal clinical phenotypes, but rather to focus on whether electronic cigarette smoke disorders the biology of the lung cells first exposed to the electronic cigarette smoke, a parameter that is the precursor of abnormalities in lung function and which is far more sensitive than lung function.
Interventions
- OTHER Group B
- OTHER Group A
- OTHER Group C
- OTHER Group D
- OTHER Group E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2014-01 |
| Est. Completion | 2018-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02188511
The ClinicalTrials.gov registry entry for NCT02188511 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Group B is the first listed.
NCT02188511 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02188511 about?
NCT02188511 is a clinical study titled "Effects of Electronic Cigarettes on Lung Biology". E-cigarettes are an increasingly popular alternate nicotine delivery system, but nothing is known about the effects of electronic cigarettes on the lungs. We hypothesize that e-cigarettes disorder airway epithelial and alveolar macrophages biology. Our goal is not to carry out a large epidemiologic ...
What is the current status of trial NCT02188511?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2014-01. Estimated completion is 2018-07.
What interventions are being tested in trial NCT02188511?
The interventions under investigation include: Group B (OTHER), Group A (OTHER), Group C (OTHER), Group D (OTHER), Group E (OTHER).
Who is sponsoring clinical trial NCT02188511?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.